Patient Portal

Close this search box.

Advancing Eye Care Through Research

At Newsom Eye, we are committed to advancing the field of eye care through rigorous research and participation in FDA studies. Our dedication to improving patient outcomes drives us to collaborate with leading researchers and institutions to investigate innovative treatments, technologies, and interventions.

Integral Participation in FDA Studies

Participation in FDA studies is integral to our mission of providing the highest quality of care to our patients. These studies allow us to evaluate the safety and effectiveness of new medications, devices, and procedures before they are made widely available to the public. By actively engaging in clinical research, we contribute to the development of groundbreaking therapies that have the potential to transform the lives of individuals affected by various eye conditions.

Diverse Range of Research

Our team of experienced physicians and researchers is actively involved in a diverse range of FDA studies spanning various ophthalmic subspecialties. From investigating novel treatments for retinal diseases to evaluating innovative surgical techniques for cataract and refractive surgery, we are at the forefront of cutting-edge research in the field of ophthalmology.

Access to Promising Therapies

By participating in FDA studies, we have the opportunity to offer our patients access to promising new therapies and interventions that may not be available elsewhere. Through carefully conducted clinical trials, we gather valuable data to assess the safety and efficacy of investigational treatments, ensuring that our patients receive the highest standard of care based on the latest scientific evidence.

Commitment to Excellence

Our commitment to excellence extends beyond providing exceptional clinical care to our patients. We are dedicated to advancing the field of ophthalmology through research, education, and innovation. By actively engaging in FDA studies, we contribute to the collective knowledge base of our profession and help shape the future of eye care.

Sharing Our Studies

As part of our ongoing commitment to transparency and patient-centered care, we are pleased to share information about some of the FDA studies in which we are currently involved. These studies represent just a portion of our ongoing research efforts aimed at improving patient outcomes and advancing the field of ophthalmology.

Some of Our Studies Include:

  • FDA Clinical Study for Segmented Bifocal Intraocular Lens, Lenstec, Inc
  • FDA Clinical Study for the Light Adjustable Intraocular Lens, RxSight.
  • FDA Clinical Study for EYEFILL Viscoelastic, Croma Pharmaceuticals, Inc
  • FDA Clinical Study for Besivance Postoperative Cataract Retrospective Surveillance, Bausch & Lomb
  • FDA Clinical Study for Besivance Postoperative LASIK Retrospective Surveillance, Bausch & Lomb
  • FDA Clinical Study for Lenstec Softec HD Intraocular Lens, Lenstec, Inc.
  • FDA Clinical Study for VISCO SHIELD Viscoelastic, OASIS Medical
  • FDA Clinical Study for Extended Depth of Focus Intraocular Lens, Alcon Labs
  • FDA Clinical Study for IC-8 Apthera small-aperture IOL, AcuFocus
  • FDA Clinical Study for the SBL-3 Multifocal IOL, Lenstec

Request An

You deserve

To request a consultation with Newsom Eye, please click link below.